Medicare Contractor Novitas Schedules Expert Panel

Pacific Edge notes its Medicare Administrative Contractor (MAC) Novitas has confirmed the scheduling of its planned Contractor Advisory Committee (CAC) to consider the evidence for urine biomarkers in patients with hematuria.

The opinions expressed during the meeting, which is scheduled to take place from 6:00pm on 19 February 2026, US ET (12:00pm Friday 20 February 2026 NZST), are expected to have an influence over the language Novitas uses in any draft Local Coverage Determination (LCD) covering Medicare reimbursement of Cxbladder that is published following the meeting.

The WebEx meeting is estimated to run for two hours and is accessible to the public by registering at the link below.

https://fcso.webex.com/weblink/register/red3f833b75a2f3922d04ada5d71a6aee

Given the significance of the CAC, Pacific Edge expects its shares to enter a trading halt ahead of the meeting that is expected to last until the company provides an announcement to investors giving context to the matters covered at the CAC. The company expects to make this announcement ahead of the market open on Monday 23 February 2026 (NZST).